Hotel Casa Amsterdam

Nov 19, 2025 8:30 AM - Nov 20, 2025 4:00 PM

Eerste Ringdijkstraat 4, NL-1097 Amsterdam, Netherlands

Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

Advanced Rates Expire on 24th September!

27

DAYS

17

HOURS

45

MINUTES

37

SECONDS

Overview

Marking 19 Years of QPPV Collaboration, Insight, and Progress

Now in its 19th year, the DIA Global QPPV Forum continues to be the only conference designed by QPPVs, for QPPVs—uniting leaders, subject matter experts, and peers from around the world in a dedicated setting for open exchange, practical learning, and professional growth.

More than just a conference, the Forum serves as a trusted environment where QPPVs can engage in meaningful discussions, reflect on evolving responsibilities, and strengthen their understanding of the systems that support patient safety. It is a uniquely neutral space where company affiliations take a back seat, titles are set aside, and participants can speak candidly confident that what is shared in the room, stays in the room.

As we look ahead to the Forum’s 20th anniversary in 2026, this year holds added significance. It offers a valuable opportunity to shape the ongoing development of the QPPV role and address the real-world challenges pharmacovigilance professionals face every day—together.

Featured topics

  • Global QPPV Challenges
  • Trends Requiring QPPV Awareness
  • Impact of Modern Technology on the Field
  • AI and Digitalisation
  • Harmonisation
  • Impact of New Local Requirements for International Qualified Persons (QPs).
  • Local QPPVs Network
  • Data Privacy
  • Globalising the PSMF – Tool for Global Understanding
  • Interaction Between the Different Local QPPVs (EU and non-EU) and the EU QPPV
  • QPPV Oversight
  • Inspections

Featured

Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV) ? You've come to the right site!

Exhibits

Highlights & Features

Who should attend?

  • QPPVs and Deputies From Any Territory
  • Regulators
  • Pharmacovigilance Consultants
  • Directors of Pharmacovigilance Oversight and Standards
  • Drug Safety Managers/Leaders
  • Auditors
  • Medical and Regulatory Affairs Experts
  • Aspiring PV Specialists/QPPVs
  • QPPV Support Staff
  •  

Need Approval in Order to Attend?

Download and fill out our justification letter to advocate to your supervisor why this is a must-attend event.

 

Download letter (CLICK HERE)

Short Course or Primer

To keep you at the forefront.

Nov 18, 2025

Pre-Conference Tutorial:

Globalisation of PSMF

Nov 18, 2025

Pre-Conference Tutorial:

Introduction to the Role of QPPVs

Program Committee

  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Deputy EU QPPV
    MSD, Netherlands
  • Katarzyna  Swiderek, MPharm, RPh
    Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
    GlaxoSmithKline, Poland
  • Angela  Van Der Salm, PhD, MSc
    Angela Van Der Salm, PhD, MSc Director PV, Managing partner
    DADA Consultancy B.V., Netherlands
  • Shahinaz  Badr, PharmD
    Shahinaz Badr, PharmD Pharmacovigilance Consultant and PVQA Auditor - EMEA
    Independent Consultant, United Arab Emirates
  • Gemma  Jimenez Sese
    Gemma Jimenez Sese Senior Director, Deputy EU QPPV
    AstraZeneca, Spain
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
    Abbvie, United Kingdom
  • Elspeth  McIntosh, MBA, RN
    Elspeth McIntosh, MBA, RN Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Ilaria  Grisoni, MSc
    Ilaria Grisoni, MSc Executive Director, Head of EU/International PV & Global Risk Management and EEA
    Gentium Srl, A Jazz Pharmaceuticals Company, Italy

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.